Mary DiBiase

Overview

Mary DiBiase received $2M in total compensation, including $426K in salary, at X4 Pharmaceuticals in 2022.

Source: SEC filing on April 25, 2023.

Related executives

We found ten more executives who work or worked at X4 Pharmaceuticals.

Paula Ragan

X4 Pharmaceuticals

Chief Executive Officer

Adam Mostafa

X4 Pharmaceuticals

Chief Financial Officer

Derek Meisner

X4 Pharmaceuticals

Chief Legal Officer

Michael Gray

X4 Pharmaceuticals

Chief Executive Officer

E FACS

X4 Pharmaceuticals

Chief Medical Officer

René BCPS

X4 Pharmaceuticals

Chief Executive Officer

Christopher Stevens

X4 Pharmaceuticals

Chief Medical Officer

David Mantus

X4 Pharmaceuticals

Former Chief Development Officer

News

You may also like